Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Amber Adams & Colton Copley. (2021) High dose naloxone for acute tizanidine overdose in the emergency department: a case report. Clinical Toxicology 59:8, pages 764-765.
Read now
Read now
J. A. Lowry & J. T. Brown. (2014) Significance of the imidazoline receptors in toxicology. Clinical Toxicology 52:5, pages 454-469.
Read now
Read now
Gerard Malanga, Raymond D Reiter & Edward Garay. (2008) Update on tizanidine for muscle spasticity and emerging indications. Expert Opinion on Pharmacotherapy 9:12, pages 2209-2215.
Read now
Read now
Leonard Kamen, Herbert R. Henney$suffix/text()$suffix/text() & Jacob D. Runyan. (2008) A practical overview of tizanidine use for spasticity secondary to multiple sclerosis, stroke, and spinal cord injury. Current Medical Research and Opinion 24:2, pages 425-439.
Read now
Read now
MathiasB. Forrester. (2007) Oxycodone Abuse in Texas, 1998–2004. Journal of Toxicology and Environmental Health, Part A 70:6, pages 534-538.
Read now
Read now
G. Randall Bond, Aris C. Garro & Donald L. Gilbert. (2007) Dyskinesias associated with atomoxetine in combination with other psychoactive drugs. Clinical Toxicology 45:2, pages 182-185.
Read now
Read now
Sasko D. Stojanovski, Renee F. Robinson, S David Baker, Marcel J. Casavant, John R. Hayes & Milap C. Nahata. (2006) Children and Adolescent Exposures to Atomoxetine Hydrochloride Reported to a Poison Control Center. Clinical Toxicology 44:3, pages 243-247.
Read now
Read now
Articles from other publishers (17)
Caleb J. Fredrickson, Kim-Long R. Nguyen & Michael E. Mullins. (2023) Phencyclidine false positive due to lamotrigine. The American Journal of Emergency Medicine 65, pages 210-211.
Crossref
Crossref
Lorenzo Villa-Zapata, Ainhoa Gómez-Lumbreras, John Horn, Malinda S. Tan, Richard D. Boyce & Daniel C. Malone. (2022) A Disproportionality Analysis of Drug–Drug Interactions of Tizanidine and CYP1A2 Inhibitors from the FDA Adverse Event Reporting System (FAERS). Drug Safety 45:8, pages 863-871.
Crossref
Crossref
Jon B. Cole & Ann M. Arens. (2022) Cardiotoxic Medication Poisoning. Emergency Medicine Clinics of North America 40:2, pages 395-416.
Crossref
Crossref
Pascal Kintz, Laurie Gheddar & Jean‐Sébastien Raul. (2021) Retracted: Liquid chromatography–tandem mass spectrometry and confirmation by liquid chromatography–high‐resolution mass spectrometry hair tests to evidence use of tizanidine by racing cyclists. Drug Testing and Analysis 14:1, pages 154-161.
Crossref
Crossref
Doaa Bader, Ahmed Adam, Mohamed Shaban & Bader Alyahya. (2021) Pediatric tizanidine toxicity reversed with naloxone: a case report. International Journal of Emergency Medicine 14:1.
Crossref
Crossref
Glenn A. Burket, B. Zane Horowitz, Robert G. Hendrickson & Gillian A. Beauchamp. (2020) Endotracheal Intubation in the Pharmaceutical-Poisoned Patient: a Narrative Review of the Literature. Journal of Medical Toxicology 17:1, pages 61-69.
Crossref
Crossref
Ross J. Miller, Brehon Davis, C. Clinton FrazeeIIIIII, Marius C. Tarau, Mary H. Dudley & Uttam Garg. 2020. Toxicology Cases for the Clinical and Forensic Laboratory. Toxicology Cases for the Clinical and Forensic Laboratory
465
467
.
Xiaolin Li & Yunpeng Jin. (2018) Irreversible profound symptomatic bradycardia requiring pacemaker after tizanidine/loxoprofen combination therapy: a case report. Journal of International Medical Research 46:6, pages 2466-2469.
Crossref
Crossref
Nathan B. Menke, Steven J. Walsh & Andrew M. King. (2015) Cardiotoxicodynamics. Emergency Medicine Clinics of North America 33:3, pages 563-595.
Crossref
Crossref
Suad A. Al-Abri, He S. Yang & Kent R. Olson. (2014) Unintentional Pediatric Ophthalmic Tetrahydrozoline Ingestion: Case Files of the Medical Toxicology Fellowship at the University of California, San Francisco. Journal of Medical Toxicology 10:4, pages 388-391.
Crossref
Crossref
Henry A. Spiller & Dennis J. Siewert. (2011) Drug‐Facilitated Sexual Assault Using Tetrahydrozoline. Journal of Forensic Sciences 57:3, pages 835-838.
Crossref
Crossref
Herbert R. HenneyIIIIII & Michael Chez. (2009) Pediatric Safety of Tizanidine. Pediatric Drugs 11:6, pages 397-406.
Crossref
Crossref
R. Palazón García, A. Benavente Valdepeñas & O. Arroyo Riaño. (2008) Protocolo de uso de la tizanidina en la parálisis cerebral infantil. Anales de Pediatría 68:5, pages 511-515.
Crossref
Crossref
Richard A Forbes, Harish Kalra, L Peter Hackett & Frank FS Daly. (2007) Deliberate self-poisoning with tiagabine: An unusual toxidrome. Emergency Medicine Australasia 19:6, pages 556-558.
Crossref
Crossref
Henry A. Spiller, Jacqualine Rogers & Tama S. Sawyer. (2007) Drug facilitated sexual assault using an over-the-counter ocular solution containing tetrahydrozoline (Visine®). Legal Medicine 9:4, pages 192-195.
Crossref
Crossref
Ramakrishna V. S. Nirogi, Vishwottam N. Kandikere, Manoj Shukla, Koteshwara Mudigonda & Santosh Maurya. (2006) Quantification of tizanidine in human plasma by liquid chromatography coupled to tandem mass spectrometry. Rapid Communications in Mass Spectrometry 20:15, pages 2286-2292.
Crossref
Crossref
C. Spitzer. 2006. Medikamentös induzierte neurologische und psychiatrische Störungen. Medikamentös induzierte neurologische und psychiatrische Störungen
73
116
.